Lifetime management of severely calcified coronary lesions: the treatment algorithm focused on the shape of calcification.
Sakakura K, Jinnouchi H, Taniguchi Y, Yamamoto K, Fujita H.
Cardiovasc Interv Ther. 2023 Oct;38(4):375-380. doi: 10.1007/s12928-023-00950-x. Epub 2023 Aug 5.
Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study.
Fezzi S, Giacoppo D, Fahrni G, Latib A, Alfonso F, Colombo A, Mahfoud F, Scheller B, Jeger R, Cortese B.
Eur Heart J. 2025 May 2;46(17):1586-1599. doi: 10.1093/eurheartj/ehaf002.
Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease.
El Amrawy AM, Loutfi MI, El Tahan SM, Ayad SW.
J Invasive Cardiol. 2021 Dec;33(12):E960-E967. doi: 10.25270/jic/20.00660. Epub 2021 Nov 24.
Mid-term clinical outcomes of new generation drug-eluting stents for treatment of diffuse coronary artery disease.
Çoner A, Çiçek D, Akıncı S, Balcıoğlu S, Altın C, Müderrisoğlu H.
Turk Kardiyol Dern Ars. 2018 Dec;46(8):659-666. doi: 10.5543/tkda.2018.10.5543/tkda.2018.62678.
Systemic coagulation-inflammation index in the prediction of ISR in patients undergoing drug-eluting stents implant: A retrospective study based on multiple machine learning methods.
Yinhua L, Hu Y, Ziyue Z, Zhou J, Lin H, Zhili J, Ting H, Huanhuan C, Zhibing L.
Int J Cardiol. 2025 Jul 1;430:133215. doi: 10.1016/j.ijcard.2025.133215. Epub 2025 Mar 31.
Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery.
Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, Airoldi F, Montorfano M, Michev I, Colombo A.
J Am Coll Cardiol. 2005 May 17;45(10):1570-3. doi: 10.1016/j.jacc.2005.01.049.
Impact of multiple and long sirolimus-eluting stent implantation on 3-year clinical outcomes in the j-Cypher Registry.
Shirai S, Kimura T, Nobuyoshi M, Morimoto T, Ando K, Soga Y, Yamaji K, Kondo K, Sakai K, Arita T, Goya M, Iwabuchi M, Yokoi H, Nosaka H, Mitsudo K; j-Cypher Registry Investigators.
JACC Cardiovasc Interv. 2010 Feb;3(2):180-8. doi: 10.1016/j.jcin.2009.11.009.
Identifying the Incidence, Predictors, Outcomes, and Prevention of Stent Thrombosis (ST) in Post-percutaneous Coronary Revascularization Patients With Drug-Eluting Stents (DES): A Systematic Review.
Sohail M, Patel P, Midha S, Shukla S, Dhamija D, Bello AO, Khan AA, Gutlapalli SD, Venugopal S.
Cureus. 2023 Sep 13;15(9):e45150. doi: 10.7759/cureus.45150. eCollection 2023 Sep.
Prognostic value of plasma pentraxin-3 levels in patients with stable coronary artery disease after drug-eluting stent implantation.
Haibo L, Xiaofang G, Chunming W, Jie Y, Guozhong C, Limei Z, Yong C, Yu F, Yingchun B, Wangjun Y, Junbo G.
Mediators Inflamm. 2014;2014:963096. doi: 10.1155/2014/963096. Epub 2014 Nov 24.
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K, Mehilli J, Byrne RA, Schulz S, Massberg S, Laugwitz KL, Vorpahl M, Seyfarth M, Kastrati A; ISAR-LEFT MAIN Study Investigators.
JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11.
